Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04330664
Title Phase 1/2 Study in Patients With Cancer Having a KRAS G12C Mutation
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Mirati Therapeutics Inc.

lung non-small cell carcinoma

Advanced Solid Tumor

colorectal cancer


MRTX849 + TNO155

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.